01 3AVIV PHARMA
02 9Accord healthcare
03 6Actavis Inc
04 6Aeon Formulations Private Limited
05 3Alphapharm PTY Ltd
06 3Annora Pharma
07 3Apotex Inc
08 5Aurobindo Pharma Limited
09 6CPS Cito Pharma Services GmbH
10 10Chartwell Pharmaceuticals llc
11 3CorePharma, LLC
12 2Eris Lifesciences
13 2Flagship Biotech International Pvt. Ltd
14 2Inventia Healthcare Limited
15 3JAMP PHARMA
16 3Krka
17 3Kusum Healthcare Pvt Ltd
18 3MINT PHARMACEUTICALS INC
19 2MS Pharma
20 7Macleods Pharmaceuticals Limited
21 6Mepha Pharma
22 1Myungmoon Pharm. Co., LTD.
23 2Neopharma
24 5Norvium
25 3PURACAP PHARM
26 3Pharmascience Inc.
27 3Prinston
28 3Sandoz B2B
29 21Takeda Pharmaceutical
30 14Teva Pharmaceutical Industries
31 5Torrent Pharmaceuticals Limited
32 2Umedica Laboratories
33 2Wanbang Biopharmaceuticals
34 3Zydus Pharmaceuticals
35 8Blank
01 6BILAYERED TABLET
02 1Dispersible Tablet
03 8SR Tablet
04 2Sustained Release Tablet
05 2TAB
06 50TABLET
07 2TABLET, EXTENDED RELEASE;ORAL
08 3TABLET; ORAL
09 72TABLET;ORAL
10 12Tabl
11 7Tablet
01 2Commercialized In: India (2004), Nigeria (2010), Ghana (2011), Jamaica (2016); Countries Registered In: India (2004), Jamaica (2012), Ghana (2011), Nigeria (2010)
02 21DISCN
03 15Generic
04 1Generic B.E study
05 2Generic CTD, BE- Available
06 3Prescription
07 53RX
08 2Registered in India (2004), Jamaica (2012), Ghana (2011), Kenya (2012), Nigeria (2010), Philippines (2010)
09 6Registered in India, Jamaica, Ghana, Kenya, Nigeria, Philippines
10 60Blank
01 3ACH-PIOGLITAZONE
02 3ACT PIOGLITAZONE
03 1ACTAZONE
04 2ACTOPLUS MET
05 2ACTOPLUS MET XR
06 3ACTOS
07 1AEOMET-G1P
08 1AEOMET-G2P
09 1AEOMET-GC1P
10 1AEOMET-GZ1P
11 1AEOMET-GZ2P
12 1AEOMET-GZ3P
13 3APO-PIOGLITAZONE
14 9Actos
15 1Aim7 30 XR
16 1Aim7 60 XR
17 2Azucar
18 2DUETACT
19 3GLUTAZONE
20 3Glidipion
21 3Glustin
22 1Glyact
23 3JAMP PIOGLITAZONE
24 3MINT-PIOGLITAZONE
25 6OSENI
26 3PIOGLITAZONE
27 45PIOGLITAZONE HYDROCHLORIDE
28 2PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
29 12PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
30 1PIOTAZ
31 3PMS-PIOGLITAZONE
32 3Paglitaz
33 6Pioglitazon-Mepha Teva
34 3Pioglitazone Accord
35 3Pioglitazone Actavis
36 1Pioglitazone Hydrochloride Tablets Macleods 15 mg
37 1Pioglitazone Hydrochloride Tablets Macleods 30 mg
38 3Pioglitazone Teva
39 3Pioglitazone Teva Pharma
40 16Blank
01 18Canada
02 2China
03 23India
04 2Jordan
05 2South Africa
06 1South Korea
07 24Sweden
08 12Switzerland
09 2U.A.E
10 77USA
11 2Blank
Regulatory Info :
Registration Country : USA
Brand Name : PIOGLITAZONE
Dosage Form : TABLET; ORAL
Dosage Strength : 15MG
Packaging :
Approval Date :
Application Number : 76799
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PIOGLITAZONE
Dosage Form : TABLET; ORAL
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number : 76799
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PIOGLITAZONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2012-10-26
Application Number : 76798
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PIOGLITAZONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 30MG BASE
Packaging :
Approval Date : 2012-10-26
Application Number : 76798
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PIOGLITAZONE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 45MG BASE
Packaging :
Approval Date : 2012-10-26
Application Number : 76798
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ACTOS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 1999-07-15
Application Number : 21073
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ACTOS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 30MG BASE
Packaging :
Approval Date : 1999-07-15
Application Number : 21073
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ACTOS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 45MG BASE
Packaging :
Approval Date : 1999-07-15
Application Number : 21073
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : ACTOPLUS MET
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2005-08-29
Application Number : 21842
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : ACTOPLUS MET
Dosage Form : TABLET;ORAL
Dosage Strength : 850MG;EQ 15MG BASE
Packaging :
Approval Date : 2005-08-29
Application Number : 21842
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : DUETACT
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG;30MG
Packaging :
Approval Date : 2006-07-28
Application Number : 21925
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : DUETACT
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG;30MG
Packaging :
Approval Date : 2006-07-28
Application Number : 21925
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : ACTOPLUS MET XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM;EQ 15MG BASE
Packaging :
Approval Date : 2009-05-12
Application Number : 22024
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : ACTOPLUS MET XR
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM;EQ 30MG BASE
Packaging :
Approval Date : 2009-05-12
Application Number : 22024
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG BASE;EQ 15MG BASE
Packaging :
Approval Date : 2013-01-25
Application Number : 22426
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG BASE;EQ 30MG BASE
Packaging :
Approval Date : 2013-01-25
Application Number : 22426
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 25MG BASE;EQ 45MG BASE
Packaging :
Approval Date : 2013-01-25
Application Number : 22426
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2013-01-25
Application Number : 22426
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 12.5MG BASE;EQ 30MG BASE
Packaging :
Approval Date : 2013-01-25
Application Number : 22426
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
Brand Name : OSENI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2013-01-25
Application Number : 22426
Regulatory Info : DISCN
Registration Country : USA
